Antimicrobial Resistance & Europe: What Happened?
Europe used to be the voice of reason in antibiotic discovery and development, but that is no longer the case. The European Medical Agency, Europe’s equivalent of the FDA, is requiring so many clinical trials for antibiotics that it is no longer feasible for companies to market the drugs in the E.U. ACSH advisor Dr. David Shlaes explains.
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!